Recall Monitor

All lots of JAMP-Clopidogrel 75 mg and AG-Clopidogrel 75 mg tablets recalled due to possible incorrect dose, which may pose health risks
Consumer Products
Sep 5th, 2024 @ 12:00 PM

Basic Details

Category: Health products - Drugs
Issue: Health products - Product safetyHealth products - Dosage
Product: JAMP-Clopidogrel 75 mg and AG-Clopidogrel 75 mg tablets
What to do: If you are taking the affected products, speak with your pharmacist as soon as possible. Continue to take your JAMP-Clopidogrel 75 mg or AG-Clopidogrel 75 mg tablets until you speak with your pharmacist and get a replacement product. Contact a health care professional immediately if you or someone you are caring for experiences serious side effects due to an incorrect dose of clopidogrel.

Products

LotDINProductExpiry
EG22CGM002
EG22CGM003
EG22CGN001
EG23CGN001
EG23CGN002
EG23CGN003
EG23CGM001
EG23CGL001
EG23CGN004		02415550JAMP-Clopidogrel 75 mg tablets2025-09-30
2025-09-30
2025-09-30
2026-05-31
2026-07-31
2026-07-31
2026-07-31
2026-07-31
2026-07-31
EG23AGH001
EG23AGM001		02431971AG-Clopidogrel 75 mg tablets2026-07-31
2026-07-31

Social

Recall Monitor

Information presented from Recalls and Safety Alerts dataset, provided by the Government of Canada through the Open Government initiative and is subject to the Open Government License.

You can access this data free of charge via Recall Monitor, or through the Healthy Canadians website.

Get personalized SMS or Email notifications about recall alerts that matter by subscribing to Recall Monitor.

Recall Monitor is not endorsed by, or is an official product of the Government of Canada.

Made with in Vancouver, BC

© Mad Filaments Software Inc.